Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform
Clicks: 685
ID: 100814
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
88.6
/100
685 views
512 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #6 of 69 articles by views in Communications biology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Rachel Graham et al. show that coronaviruses with extensively rewired transcription regulatory networks are effective vaccine candidates against Severe Acute Respiratory Syndrome Coronavirus. The reversion of live-attenuated vaccine strains to virulence can be avoided with these vaccines.
| Reference Key |
graham2018evaluationcommunications
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Graham, Rachel L.;Deming, Damon J.;Deming, Meagan E.;Yount, Boyd L.;Baric, Ralph S.; |
| Journal | Communications biology |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.